Albendazole Anthelmintic Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Tablets, Capsules, Others); Application (Human, Veterinary) and Geography

Report Code: TIPRE00022893 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Albendazole is in a class of drugs known as anthelmintics medication, also known as albendazolum. It inhibits the production or replication of newly hatched insect larvae (worms) in the body. It is used to treat various infections caused by worms such as pork tapeworm and dog tapeworm. It can be used for various purposes in humans and animals. In animals, it is used to treat capillariasis that is caused by Capillaria plica (dogs and cats) and C. felis cati (cats). Capillaria infect the urinary bladder, so they are sometimes referred to as bladder worms. Additionally, it has been used to treat filaroides infections and giardia infections in dogs. It works by stopping sugar absorption by worms, so the energy production is diminished and results in immobilization and death of the parasite.

MARKET SCOPE

The "Global Albendazole Anthelmintic Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the albendazole anthelmintic drug market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading albendazole anthelmintic drug market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global albendazole anthelmintic drug market is segmented into tablets, capsules and others.
  •  On the basis of application, the market is bifurcated into human and veterinary.

MARKET DYNAMICS
Drivers

  •  Growing incidences of neurocysticercosis infection and high prevalence of human parasitic worm infections drive the albendazole anthelmintic drug market.
  •  Rising awareness about soil-transmitted infections and filarial infections in humans and rising incidences of helminthic infection boosts the market growth.
  •  Rise in awareness about veterinary care favour growth of the global market.
  •  Growing government initiatives for creating awareness to eradicate the infection and increasing awareness about combination therapy in order to reduce the drug resistance in animals propel market growth.
  •  Rising innovations in anthelmintic drugs and expanding R&D activities for new drug development fuel the market growth.

Restraints

  •  Side effects associated with albendazole anthelmintic drugs.
  •  Rise in multidrug-resistance.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The albendazole anthelmintic drug market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the albendazole anthelmintic drug market in these regions.

IMPACT OF COVID-19 ON ALBENDAZOLE ANTHELMINTIC DRUG MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The outbreak of COVID-19, has surged an unprecedented demand for medication that are capable of fighting off the novel coronavirus infection. Some companies are validating promising potentials of anthelmintic drug therapy for treatment of COVID-19. As a result, niclosamide has been found to be potentially effective in many countries for treating coronavirus patients. Hence, this led to increased drug demand in the market. Companies in the anthelmintic drugs market are taking extra efforts to conduct clinical trials in existing therapeutic drugs that may be effective in coronavirus treatment, this overall results in high demand for albendazole anthelmintic drug in the forecast period.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the albendazole anthelmintic drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from albendazole anthelmintic drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for albendazole anthelmintic drug in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the albendazole anthelmintic drug market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Amneal Pharmaceuticals Inc
  •  Cipla Inc.
  •  Sun Pharmaceutical Industries Ltd
  •  GlaxoSmithKline
  •  Salius Pharma
  •  Sequent Scientific
  •  K.A. Malle Pharmaceuticals
  •  Jiangsu Qihui
  •  Supharma Chem
  •  Fredun Pharmaceuticals Ltd

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Albendazole Anthelmintic Drug Market - By Type
1.3.2 Albendazole Anthelmintic Drug Market - By Application
1.3.3 Albendazole Anthelmintic Drug Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ALBENDAZOLE ANTHELMINTIC DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ALBENDAZOLE ANTHELMINTIC DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ALBENDAZOLE ANTHELMINTIC DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. ALBENDAZOLE ANTHELMINTIC DRUG - GLOBAL MARKET OVERVIEW
6.2. ALBENDAZOLE ANTHELMINTIC DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. ALBENDAZOLE ANTHELMINTIC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TABLETS
7.3.1. Overview
7.3.2. Tablets Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ALBENDAZOLE ANTHELMINTIC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HUMAN
8.3.1. Overview
8.3.2. Human Market Forecast and Analysis
8.4. VETERINARY
8.4.1. Overview
8.4.2. Veterinary Market Forecast and Analysis

9. ALBENDAZOLE ANTHELMINTIC DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Albendazole Anthelmintic Drug Market Overview
9.1.2 North America Albendazole Anthelmintic Drug Market Forecasts and Analysis
9.1.3 North America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Type
9.1.4 North America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Application
9.1.5 North America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Albendazole Anthelmintic Drug Market
9.1.5.1.1 Canada Albendazole Anthelmintic Drug Market by Type
9.1.5.1.2 Canada Albendazole Anthelmintic Drug Market by Application
9.1.5.2 Mexico Albendazole Anthelmintic Drug Market
9.1.5.2.1 Mexico Albendazole Anthelmintic Drug Market by Type
9.1.5.2.2 Mexico Albendazole Anthelmintic Drug Market by Application
9.1.5.3 US Albendazole Anthelmintic Drug Market
9.1.5.3.1 US Albendazole Anthelmintic Drug Market by Type
9.1.5.3.2 US Albendazole Anthelmintic Drug Market by Application
9.2. EUROPE
9.2.1 Europe Albendazole Anthelmintic Drug Market Overview
9.2.2 Europe Albendazole Anthelmintic Drug Market Forecasts and Analysis
9.2.3 Europe Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Type
9.2.4 Europe Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Albendazole Anthelmintic Drug Market
9.2.5.1.1 Germany Albendazole Anthelmintic Drug Market by Type
9.2.5.1.2 Germany Albendazole Anthelmintic Drug Market by Application
9.2.5.2 France Albendazole Anthelmintic Drug Market
9.2.5.2.1 France Albendazole Anthelmintic Drug Market by Type
9.2.5.2.2 France Albendazole Anthelmintic Drug Market by Application
9.2.5.3 Italy Albendazole Anthelmintic Drug Market
9.2.5.3.1 Italy Albendazole Anthelmintic Drug Market by Type
9.2.5.3.2 Italy Albendazole Anthelmintic Drug Market by Application
9.2.5.4 Spain Albendazole Anthelmintic Drug Market
9.2.5.4.1 Spain Albendazole Anthelmintic Drug Market by Type
9.2.5.4.2 Spain Albendazole Anthelmintic Drug Market by Application
9.2.5.5 United Kingdom Albendazole Anthelmintic Drug Market
9.2.5.5.1 United Kingdom Albendazole Anthelmintic Drug Market by Type
9.2.5.5.2 United Kingdom Albendazole Anthelmintic Drug Market by Application
9.2.5.6 Rest of Europe Albendazole Anthelmintic Drug Market
9.2.5.6.1 Rest of Europe Albendazole Anthelmintic Drug Market by Type
9.2.5.6.2 Rest of Europe Albendazole Anthelmintic Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Albendazole Anthelmintic Drug Market Overview
9.3.2 Asia-Pacific Albendazole Anthelmintic Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Albendazole Anthelmintic Drug Market
9.3.5.1.1 Australia Albendazole Anthelmintic Drug Market by Type
9.3.5.1.2 Australia Albendazole Anthelmintic Drug Market by Application
9.3.5.2 China Albendazole Anthelmintic Drug Market
9.3.5.2.1 China Albendazole Anthelmintic Drug Market by Type
9.3.5.2.2 China Albendazole Anthelmintic Drug Market by Application
9.3.5.3 India Albendazole Anthelmintic Drug Market
9.3.5.3.1 India Albendazole Anthelmintic Drug Market by Type
9.3.5.3.2 India Albendazole Anthelmintic Drug Market by Application
9.3.5.4 Japan Albendazole Anthelmintic Drug Market
9.3.5.4.1 Japan Albendazole Anthelmintic Drug Market by Type
9.3.5.4.2 Japan Albendazole Anthelmintic Drug Market by Application
9.3.5.5 South Korea Albendazole Anthelmintic Drug Market
9.3.5.5.1 South Korea Albendazole Anthelmintic Drug Market by Type
9.3.5.5.2 South Korea Albendazole Anthelmintic Drug Market by Application
9.3.5.6 Rest of Asia-Pacific Albendazole Anthelmintic Drug Market
9.3.5.6.1 Rest of Asia-Pacific Albendazole Anthelmintic Drug Market by Type
9.3.5.6.2 Rest of Asia-Pacific Albendazole Anthelmintic Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Albendazole Anthelmintic Drug Market Overview
9.4.2 Middle East and Africa Albendazole Anthelmintic Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Albendazole Anthelmintic Drug Market
9.4.5.1.1 South Africa Albendazole Anthelmintic Drug Market by Type
9.4.5.1.2 South Africa Albendazole Anthelmintic Drug Market by Application
9.4.5.2 Saudi Arabia Albendazole Anthelmintic Drug Market
9.4.5.2.1 Saudi Arabia Albendazole Anthelmintic Drug Market by Type
9.4.5.2.2 Saudi Arabia Albendazole Anthelmintic Drug Market by Application
9.4.5.3 U.A.E Albendazole Anthelmintic Drug Market
9.4.5.3.1 U.A.E Albendazole Anthelmintic Drug Market by Type
9.4.5.3.2 U.A.E Albendazole Anthelmintic Drug Market by Application
9.4.5.4 Rest of Middle East and Africa Albendazole Anthelmintic Drug Market
9.4.5.4.1 Rest of Middle East and Africa Albendazole Anthelmintic Drug Market by Type
9.4.5.4.2 Rest of Middle East and Africa Albendazole Anthelmintic Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Albendazole Anthelmintic Drug Market Overview
9.5.2 South and Central America Albendazole Anthelmintic Drug Market Forecasts and Analysis
9.5.3 South and Central America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Type
9.5.4 South and Central America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Albendazole Anthelmintic Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Albendazole Anthelmintic Drug Market
9.5.5.1.1 Brazil Albendazole Anthelmintic Drug Market by Type
9.5.5.1.2 Brazil Albendazole Anthelmintic Drug Market by Application
9.5.5.2 Argentina Albendazole Anthelmintic Drug Market
9.5.5.2.1 Argentina Albendazole Anthelmintic Drug Market by Type
9.5.5.2.2 Argentina Albendazole Anthelmintic Drug Market by Application
9.5.5.3 Rest of South and Central America Albendazole Anthelmintic Drug Market
9.5.5.3.1 Rest of South and Central America Albendazole Anthelmintic Drug Market by Type
9.5.5.3.2 Rest of South and Central America Albendazole Anthelmintic Drug Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ALBENDAZOLE ANTHELMINTIC DRUG MARKET, KEY COMPANY PROFILES
11.1. AMNEAL PHARMACEUTICALS INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CIPLA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SUN PHARMACEUTICAL INDUSTRIES LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SALIUS PHARMA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SEQUENT SCIENTIFIC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. K.A. MALLE PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JIANGSU QIHUI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUPHARMA CHEM
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. FREDUN PHARMACEUTICALS LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Amneal Pharmaceuticals Inc
2. Cipla Inc.
3. Sun Pharmaceutical Industries Ltd
4. GlaxoSmithKline
5. Salius Pharma
6. Sequent Scientific
7. K.A. Malle Pharmaceuticals
8. Jiangsu Qihui
9. Supharma Chem
10. Fredun Pharmaceuticals Ltd
TIPRE00022893
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking